Search results
Results from the WOW.Com Content Network
Eric Poehlman (US), a former Professor in the Department of Medicine at the University of Vermont, was convicted in 2005 of grant fraud after falsifying data in as many as 17 grant applications between 1992 and 2000. He was the first academic in the United States to be jailed for falsifying data in a grant application.
But the report submitted by Liberty to the state workers compensation program in June 2020 listed a different doctor’s name as the author of the report, prosecutors said.
In 2002, he was convicted of pharmaceutical fraud and sentenced to federal prison. [33] Greenberg v. Miami Children's Hospital Research Institute: United States Florida: 2003 Patients donated tissue samples, which researchers subsequently used in a plan to generate profit. GlaxoSmithKline human experiments Various 2004–2012
In March 2011, Van Parijs pleaded guilty in a U.S. District Court in Boston to one count of making a false statement on a federal grant application. The government asked Judge Denise Casper for a 6-month jail term because of the seriousness of the fraud, which involved a $2-million grant. After several prominent scientists including Van Parijs ...
Four men face charges from the Orange County district attorney's office in connection with allegedly billing nearly $100 million in fraudulent fees.
Health care fraud includes "snake oil" marketing, health insurance fraud, drug fraud, and medical fraud. Health insurance fraud occurs when a company or an individual defrauds an insurer or government health care program, such as Medicare (United States) or equivalent State programs. The manner in which this is done varies, and persons engaging ...
Two Miami-Dade State Attorney’s Office employees have been demoted after supervisors discovered a backlog of 700-plus fraud complaints stretching back years. The result: Hundreds of cases cannot ...
Legal claims against the pharmaceutical industry have varied widely over the past two decades, including Medicare and Medicaid fraud, off-label promotion, and inadequate manufacturing practices. [ 3 ] [ 4 ] With respect to off-label promotion, specifically, a federal court recognized off-label promotion as a violation of the False Claims Act ...